Precision Medicine Market Growth and Survey, 2018-2028 Precision Medicine Market Growth and Survey | Page 4

List of Figures 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. Precision Medicine: Treatment Tailored to an Individual’s Genetic Structure Precision Medicine – a Multi-Faceted Approach to Patient Care Chronic Conditions: Key Statistics: 2017 Long-Term Growth Drivers Impact Analysis Global Precision Medicine Market Snapshot Dominating Segments of Global Precision Medicine Market, 2017 and 2028 Global Precision Medicine Market (by Ecosystem), 2017 and 2028 Global Precision Medicine Market, (by Application), 2017 and 2028 Global Precision Medicine Market (by Region), 2017 and 2028 Notable Areas of Strategic Focus across Influential Countries Strategies Incorporated to Expand the Global Reach Precision Medicine Funding for Academic Institutions and Research Organizations A Persuasive Market Entry Strategy for Diagnostics and Pharma & Biotech Companies to Capitalize on Precision Medicine Plausible Market Penetration Strategy to Shape the Future of Healthcare Go To Market Strategy Value Assessment Frameworks Product/Service Promotion Strategies Precision Medicine: A Trigger to Unfold Innovative Business Model Fixable Gaps in the Field of Precision Medicine Estimated Ratios of Cost per Quality-Adjusted Life Year (QALY) Gained for Precision or Personalized Medicine Tests Impact of Precision Medicine on Researchers, Manufacturers, and Consumers Opportunities and Challenges for Researchers, Providers, and Patients 24. Precision Medicine Approach 25. Evolution of Precision Medicine Technology 26. Precision Medicine: Remodeling the One-Size-Fits- All Theory to Individually Tailored Therapy 27. Precision Medicine: Remodeling Framework 28. Precision Medicine: Enabling Technologies 29. Structured Big Data Reporting Benefits 30. Generalized Process for the Microarray 31. Market Dynamics of Global Precision Medicine Market 32. Total Number of Genetic Products in Market 33. Total Number of Genetic Products in Market 34. % of Patients Whose Tumors Were Driven by Certain Genetic Mutations That Could Be Targets for Specific Drugs 35. Gene Therapy Products in Pipeline 36. Sales Forecast for Gene Therapy Products (Yescarta and Kymriah), $ Million 37. Precision Medicine Deals (2010-2017) 38. Competitive Landscape, January 2012-December 2018 39. Share of Key Developments and Strategies (January 2012-December 2018) 40. Joint Ventures, Partnerships, Agreements, and Collaborations Share by Companies (January 2012-December 2018) 41. Product launches, Enhancements, and Upgradation Share by Companies (January 2012-December 2018) 42. Product Approvals Share by Companies (January 2012-December 2018) 43. Merger and Acquisitions Share by Companies (January 2012-December 2018) 44. Business Expansion Share by Companies (January 2012-December 2018) 45. Other Developments Share by Companies (January 2012-December 2018) 46. Market Share Analysis by Applied Sciences, 2017 47. Market Share Analysis by Precision Diagnostics, 2017 48. Market Share Analysis by Precision Therapeutics, 2017 49. Market Share Analysis by Digital Health and IT, 2017 50. Porter’s Five Forces Analysis 51. Definition of Suppliers and Buyers in the Precision Medicine Market 52. Bargaining Power of Suppliers: Overall Impact, 2015-2028 53. Bargaining Power of Buyers: Overall Impact, 2015-2028 54. Threat of New Entrant: Overall Impact, 2015-2028 55. Threat of Substitute Products: Overall Impact, 2014-2028 56. Intensity of Competitive Rivalry: Overall Impact, 2015-2028 57. Supply Chain Analysis: Global Precision Medicine Market [email protected] | www.bisresearch.com